Morbihan Syndrome is an uncommon condition characterized by the slow appearance of erythema and solid edema on the upper portion of the face. The disease is considered an end-stage complication of rosacea's recurrent episodes of vascular dilation and inflammation or a complication of acne vulgaris. The disease is often insidious to diagnose and challenging to treat. We report a paradigmatic case of unilateral Morbihan Syndrome induced by use of fullface CPAP masks for OSAS in a patient with rosacea. OSAS could play a role in the development of rosacea symptoms. Our aim is to remark the importance of a careful, prolonged follow-up to optimize patient's management and to improve the adherence to therapy.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251524 | PMC |
| http://dx.doi.org/10.4081/dr.2021.9270 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Novel prognostic factors and combination therapy outcomes in Morbihan disease: insights from an Asian population.
BMC Ophthalmol
November 2024
Department of Ophthalmology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, #222 Banpo-daero, Seocho-gu, Seoul, 06591, Korea.
Purpose: This study aimed to identify novel prognostic factors for Morbihan disease (MD) treatment outcomes and evaluate the efficacy of combination therapy in an Asian population, addressing the gaps in current understanding of this rare condition.
Methods: We conducted a retrospective analysis of MD patients diagnosed and treated at a tertiary hospital between 2017 and 2023. Patients received combinations of oral medications (tetracycline, isotretinoin, corticosteroids), topical treatments (tacrolimus, ivermectin), and intralesional steroid injections.
Thalidomide Combined With Minocycline for Successful Treatment of Morbihan Syndrome Patients in Two Cases.
Am J Ther
September 2024
Department of Dermatology, Chongqing Hospital of Traditional Chinese Medicine (Chongqing Clinical Research Center for Dermatology; Chongqing Key Laboratory of Integrative Dermatology Research), Chongqing, P.R. China ; and.
Successful treatment of a Morbihan's disease patient after a therapeutic challenge: A case report and comprehensive literature review.
J Gen Fam Med
July 2024
Department of Dermatology, Rasool Akram Medical Complex Clinical Research Development Center (RCRDC), School of Medicine Iran University of Medical Sciences (IUMS) Tehran Iran.
Article Synopsis
- Morbihan's disease is a rare condition that leads to chronic swelling of the face, with unclear causes related to blood vessel and lymphatic system issues.
- Traditional treatments are usually not effective, and there’s no widely accepted successful therapy for the condition.
- A case study of a 17-year-old male showed improvement using a new combination treatment of cromolyn sodium nasal spray and oral montelukast, which had not been previously reported for this syndrome.
Morbihan Disease: A Rare Case of Periorbital Bilateral Edema with Histopathological Findings of Chronic Inflammation and Demodex Localization.
Am J Case Rep
June 2024
Department of Ophthalmology, IRCCS Humanitas Research Hospital, Milan, Italy.
BACKGROUND Morbihan disease, also known as Morbihan syndrome, is a rare medical condition characterized by chronic facial edema predominantly affecting the upper two-thirds of the face. Despite being recognized in medical literature for decades, its true prevalence and underlying pathophysiology remain poorly understood. Various hypotheses, including impaired lymphatic drainage, abnormal vascular permeability, immune dysregulation, and inflammatory reactions to demodex infestation, have been proposed to explain the etiology.
View Article and Find Full Text PDFIf not angioedema, what is it? Diagnostic approach to facial edema.
J Dtsch Dermatol Ges
April 2024
Departamento de Eczema de Contacto e Inmunoalergia, Servicio de Dermatología Médico-Quirúrgica y Venereología, Hospital Universitario San Cecilio, Granada, Spain.
Article Synopsis
- Facial edema is a common issue in patients visiting allergology and dermatology clinics, but diagnosing its cause can be difficult for doctors.
- Facial angioedema has multiple underlying causes, such as histaminergic and bradykinergic responses, which need to be differentiated from other conditions like infections and autoimmune diseases.
- A thorough diagnostic strategy is crucial for conducting the right tests and administering effective treatment for facial edema-related conditions.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!